153 related articles for article (PubMed ID: 33886401)
21. The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis.
Boyle DL; Soma K; Hodge J; Kavanaugh A; Mandel D; Mease P; Shurmur R; Singhal AK; Wei N; Rosengren S; Kaplan I; Krishnaswami S; Luo Z; Bradley J; Firestein GS
Ann Rheum Dis; 2015 Jun; 74(6):1311-6. PubMed ID: 25398374
[TBL] [Abstract][Full Text] [Related]
22. Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement.
Orsolini G; Bertoldi I; Rossini M
Clin Rheumatol; 2020 Mar; 39(3):727-736. PubMed ID: 31970549
[TBL] [Abstract][Full Text] [Related]
23. Flexible two-layer dissolving and safing microneedle transdermal of neurotoxin: A biocomfortable attempt to treat Rheumatoid Arthritis.
Yao W; Tao C; Zou J; Zheng H; Zhu J; Zhu Z; Zhu J; Liu L; Li F; Song X
Int J Pharm; 2019 May; 563():91-100. PubMed ID: 30890451
[TBL] [Abstract][Full Text] [Related]
24. Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid Arthritis.
Wei X; Wu J; Zhao G; Galdamez J; Lele SM; Wang X; Liu Y; Soni DM; Purdue PE; Mikuls TR; Goldring SR; Wang D
Mol Pharm; 2018 Aug; 15(8):3456-3467. PubMed ID: 29966420
[TBL] [Abstract][Full Text] [Related]
25. Co-Delivery of Loxoprofen and Tofacitinib by Photothermal Microneedles for Rheumatoid Arthritis Treatment.
Lu Y; Xiao T; Lai R; Liu Z; Luo W; Wang Y; Fu S; Chai G; Jia J; Xu Y
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242742
[TBL] [Abstract][Full Text] [Related]
26. Recent trends, challenges and future outlook of transdermal drug delivery systems for rheumatoid arthritis therapy.
Qindeel M; Ullah MH; Fakhar-Ud-Din ; Ahmed N; Rehman AU
J Control Release; 2020 Nov; 327():595-615. PubMed ID: 32920080
[TBL] [Abstract][Full Text] [Related]
27. Flexible nano-liposomes-based transdermal hydrogel for targeted delivery of dexamethasone for rheumatoid arthritis therapy.
Zhao YP; Han JF; Zhang FY; Liao TT; Na R; Yuan XF; He GB; Ye W
Drug Deliv; 2022 Dec; 29(1):2269-2282. PubMed ID: 35815790
[TBL] [Abstract][Full Text] [Related]
28. Sodium alginate microneedle arrays mediate the transdermal delivery of bovine serum albumin.
Demir YK; Akan Z; Kerimoglu O
PLoS One; 2013; 8(5):e63819. PubMed ID: 23675508
[TBL] [Abstract][Full Text] [Related]
29. Transdermal enhancement strategy of ketoprofen and teriflunomide: The effect of enhanced drug-drug intermolecular interaction by permeation enhancer on drug release of compound transdermal patch.
Liu C; Guan Y; Tian Q; Shi X; Fang L
Int J Pharm; 2019 Dec; 572():118800. PubMed ID: 31678378
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of Tofacitinib in the Treatment of Moderate to Severe Rheumatoid Arthritis in South Korea.
Lee MY; Park SK; Park SY; Byun JH; Lee SM; Ko SK; Lee EK
Clin Ther; 2015 Aug; 37(8):1662-76.e2. PubMed ID: 26243076
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of ultrasound mediated microbubbles in diclofenac gel to enhance transdermal permeation in rheumatoid arthritis induced rat.
Liao AH; Chuang HC; Chung HY
Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():3521-4. PubMed ID: 26737052
[TBL] [Abstract][Full Text] [Related]
32. Polymeric microneedle-mediated transdermal delivery of melittin for rheumatoid arthritis treatment.
Du G; He P; Zhao J; He C; Jiang M; Zhang Z; Zhang Z; Sun X
J Control Release; 2021 Aug; 336():537-548. PubMed ID: 34237400
[TBL] [Abstract][Full Text] [Related]
33. Tofacitinib citrate-based liposomes for effective treatment of rheumatoid arthritis.
Shen Q; Shu H; Xu X; Shu G; Du Y; Ying X
Pharmazie; 2020 Apr; 75(4):131-135. PubMed ID: 32295688
[TBL] [Abstract][Full Text] [Related]
34. Development of an intelligent, stimuli-responsive transdermal system for efficient delivery of Ibuprofen against rheumatoid arthritis.
Khan D; Qindeel M; Ahmed N; Asad MI; Shah KU; Asim Ur Rehman
Int J Pharm; 2021 Dec; 610():121242. PubMed ID: 34737113
[TBL] [Abstract][Full Text] [Related]
35. Tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis: a cost-effectiveness analysis compared with adalimumab in Taiwan.
Chen DY; Hsu PN; Tang CH; Claxton L; Valluri S; Gerber RA
J Med Econ; 2019 Aug; 22(8):777-787. PubMed ID: 30982378
[No Abstract] [Full Text] [Related]
36. Potential of Sonophoresis as a Skin Penetration Technique in the Treatment of Rheumatoid Arthritis with Transdermal Patch.
Vaidya J; Shende P
AAPS PharmSciTech; 2020 Jun; 21(5):180. PubMed ID: 32601758
[TBL] [Abstract][Full Text] [Related]
37. Tofacitinib in the Treatment of Rheumatoid Arthritis and Chronic Plaque Psoriasis.
Gupta AK; Cernea M; Lynde CW
Skin Therapy Lett; 2017 Mar; 22(2):1-7. PubMed ID: 28329404
[TBL] [Abstract][Full Text] [Related]
38. Effect of the combination of permeation enhancer and ion-pairs strategies on transdermal delivery of tofacitinib.
Song H; Liu C; Ruan J; Yang D; Zhong T; Liu Y; Fang L
Int J Pharm; 2022 Jan; 611():121190. PubMed ID: 34662645
[TBL] [Abstract][Full Text] [Related]
39. Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme.
Curtis JR; Lee EB; Kaplan IV; Kwok K; Geier J; Benda B; Soma K; Wang L; Riese R
Ann Rheum Dis; 2016 May; 75(5):831-41. PubMed ID: 25902789
[TBL] [Abstract][Full Text] [Related]
40. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
Kshirsagar SJ; Bhalekar MR; Mohapatra SK
Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
